LEBANON, N.H.—Celdara Medical today announced today announced the appointment of Dr. Wayne Frederick, MD, MBA as advisor to its board of directors. Dr. Frederick is President Emeritus of Howard University and the Charles R. Drew Professor of Surgery at the Howard University College of Medicine. He is an active board […]
LEBANON, N.H.—Celdara Medical today announced the appointment of Lynne Parshall, JD to the company’s board of directors. “Lynne is an inspiring leader who knows exactly what it takes to transform world-changing concepts into valuable medicines. Her tenure as founding COO and Director at Ionis clearly demonstrates her thought leadership, delivering […]
LEBANON, N.H. and TUCSON, Ariz.– Celdara Medical and Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) today announced the signing of a Memorandum of Understanding (MOU) aimed at identifying and advancing promising new therapeutics in areas of high unmet medical need. Under the terms of this agreement, both organizations look […]
Celdara Medical and ARMI Partner to Accelerate Commercialization of Regional Biofabrication Technologies Lebanon, NH: Celdara Medical today announced a partnership with the Advanced Regenerative Manufacturing Institute (ARMI) to support and advise ARMI’s newly-created BioFab Startup Lab and its portfolio companies. The BioFab Startup Lab includes companies that are developing medical […]
Lebanon, NH: Celdara Medical is pleased to congratulate one of its Scientific Founders, Dr. Charles Sentman, on his recent selection as a 2022 National Academy of Inventors (NAI) Fellow. The NAI Fellows Program honors academic inventors who have demonstrated a prolific spirit of innovation in creating inventions with tangible impact […]
Lebanon, NH: Celdara Medical, LLC today announced Dr. Jonathan Heller as its first Entrepreneur in Residence (EIR). Celdara Medical is developing a diverse portfolio of preclinical therapeutic assets, platforms, and companies. Heller is primarily responsible for advancing one of Celdara’s lead therapeutic programs to spin-out or exit. “Celdara’s pipeline […]
Celdara Medical Receives Funding to Develop Broad-Spectrum Antimicrobials for Chronic Lung Infection Lebanon, NH: The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) has awarded Celdara Medical, LLC a Phase I Small Business Innovation Research (SBIR) grant for development of broad-spectrum antimicrobial peptides […]
Lebanon, NH: Celdara Medical, LLC announced today that the National Cancer Institute (NCI) of the National Institutes of Health (NIH) has awarded a Phase II Small Business Innovation Research (SBIR) Fast-Track grant to fund company’s ongoing development of CM-CX1, a chimeric antigen receptor (CAR) T cell therapy for the treatment […]
Celdara Medical, LLC today announced that the National Institute of Aging’s Research and Entrepreneurial Development Immersion (REDI) initiative has awarded an R25 Entrepreneurship Enhancement Award to fund the company’s comprehensive training program focused on Alzheimer’s Disease: the Alzheimer’s-focused Celdara Medical High-Potential Entrepreneurs’ Fellowship (A-CHEF). This project builds on Celdara Medical’s […]
Position Description Celdara Medical, LLC (CM) is developing a portfolio of preclinical therapeutic assets, platforms, and companies. Each of these has a different development path, and we work with many different modalities, and in many different indications, but everything we do is singularly focused on saving lives and/or improving quality […]